Search Results 501-510 of 16930 for Neuroimaging
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...
About this study. A brain PET scan is recognized as "reasonable and necessary" for some patients with "a recently established diagnosis of dementia" ...
Neurodegeneration, neuroregeneration, neurogenetics, neuroengineering, neuroimaging · Regenerative Sciences. Regenerative diagnostics and therapeutics ...
The purpose o fthis study. A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within ...
The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...
Normal neuroimaging except for changes expected for PLS; No active major neurological diseases other than PLS and no history of major neurological diseases ...
... Neuroimaging Initiative. Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease. J Alzheimers Dis. 2018; 62 (2):621-633. View PubMed ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.